157 related articles for article (PubMed ID: 14975592)
1. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis.
Diab A; Hussain RZ; Lovett-Racke AE; Chavis JA; Drew PD; Racke MK
J Neuroimmunol; 2004 Mar; 148(1-2):116-26. PubMed ID: 14975592
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis.
Diab A; Deng C; Smith JD; Hussain RZ; Phanavanh B; Lovett-Racke AE; Drew PD; Racke MK
J Immunol; 2002 Mar; 168(5):2508-15. PubMed ID: 11859145
[TBL] [Abstract][Full Text] [Related]
3. Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia.
Xu J; Storer PD; Chavis JA; Racke MK; Drew PD
J Neurosci Res; 2005 Aug; 81(3):403-11. PubMed ID: 15968640
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
Natarajan C; Bright JJ
Genes Immun; 2002 Apr; 3(2):59-70. PubMed ID: 11960303
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
6. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY; Cho IJ; Kim SG
Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
Feinstein DL; Galea E; Gavrilyuk V; Brosnan CF; Whitacre CC; Dumitrescu-Ozimek L; Landreth GE; Pershadsingh HA; Weinberg G; Heneka MT
Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
[TBL] [Abstract][Full Text] [Related]
9. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
[TBL] [Abstract][Full Text] [Related]
10. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2).
Kielian T; McMahon M; Bearden ED; Baldwin AC; Drew PD; Esen N
J Neurochem; 2004 Sep; 90(5):1163-72. PubMed ID: 15312171
[TBL] [Abstract][Full Text] [Related]
11. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
[TBL] [Abstract][Full Text] [Related]
12. Hormone regulation of microglial cell activation: relevance to multiple sclerosis.
Drew PD; Storer PD; Xu J; Chavis JA
Brain Res Brain Res Rev; 2005 Apr; 48(2):322-7. PubMed ID: 15850670
[TBL] [Abstract][Full Text] [Related]
13. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor-alpha exert synergistic antiproliferative effects on human coronary artery smooth muscle cells.
Benson S; Padmanabhan S; Kurtz TW; Pershadsingh HA
Mol Cell Biol Res Commun; 2000 Mar; 3(3):159-64. PubMed ID: 10860864
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis.
Storer PD; Xu J; Chavis J; Drew PD
J Neuroimmunol; 2005 Apr; 161(1-2):113-22. PubMed ID: 15748950
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease.
Lovett-Racke AE; Hussain RZ; Northrop S; Choy J; Rocchini A; Matthes L; Chavis JA; Diab A; Drew PD; Racke MK
J Immunol; 2004 May; 172(9):5790-8. PubMed ID: 15100326
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis.
Polak PE; Kalinin S; Dello Russo C; Gavrilyuk V; Sharp A; Peters JM; Richardson J; Willson TM; Weinberg G; Feinstein DL
J Neuroimmunol; 2005 Nov; 168(1-2):65-75. PubMed ID: 16098614
[TBL] [Abstract][Full Text] [Related]
18. Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta(12,14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2.
Garcia Palacios V; Morita I; Murota S
Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):215-21. PubMed ID: 11728175
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
Chung SW; Kang BY; Kim TS
Mol Pharmacol; 2003 Nov; 64(5):1169-79. PubMed ID: 14573767
[TBL] [Abstract][Full Text] [Related]
20. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
